To Check The Efficacy of Chandrakala Choorna And Navayas choorna in Bahupitta Kamala CHOORNA IN BAHUPITTA KAMALA HEPATITIS

A COMPARATIVE STUDY OF CHANDRAKALA CHOORNA AND NAVAYAS CHOORNA IN BAHUPITTA KAMALA HEPATITIS - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064166

Enrollment

Registered

2024-03-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K768- Other specified diseases of liver

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnosed Subject of Bahupitta Kamala (Hepatitis) will be selected as per signs and symptoms described in Ayurved Samhitas. 2) Subject in between 18 and 70 years of age will be selected irrespective of their gender, social and economic status. 3) Subject showing total serum bilirubin 1 to 10 mg/dl

Exclusion criteria

Exclusion criteria: 1) Subject with other complication like malignancy. 2) Subject with known cases of Autoimmune Hepatitis, primary biliary cholangitis. 3) Subject with immuno-compromised status. 4) Subject with gall bladder disorders. 5) Pregnant women and Lactating mother. 6) Those subjects who have taken Hepatitis B and C vaccine.

Design outcomes

Primary

Measure	Time frame
1.Reduction of Sign and Symptoms of Bahupitta Kamala (Hepatitis) by two grades.Timepoint: 28 days	—

Secondary

Measure	Time frame
1.Reduction of Bilirubin level to normal range. 2. Reduction of SGPT and SGOT value to the normal.Timepoint: Baseline, 7th,14th,21th and 28th Day follow up.	—

Countries

India

Contacts

Public ContactDR SANJAY A DHURVE

Bharati Vidyapeeth Deemed to be University College of Ayurved

sanjay.dhurve@bharatividyapeeth.edu9850044207

Outcome results